Curaleaf 

Curaleaf Holdings, Inc. functions as a leading cannabis enterprise within the United States. The company's activities are organized into two distinct divisions: Cannabis Operations and Non-Cannabis Operations. Its Cannabis Operations segment is dedicated to the cultivation, processing, and distribution of cannabis products, reaching consumers through both its own retail outlets and wholesale partnerships. Conversely, the Non-Cannabis Operations segment delivers a suite of professional services to licensed medical and adult-use cannabis businesses, typically structured under management service agreements. These offerings include expertise in cultivation, processing, and retail management, as well as administrative back-office support, intellectual property rights, real estate leases, and financial lending facilities. Curaleaf's comprehensive product line encompasses a wide array of cannabis formats, such as raw flower, pre-rolls, flower pods, and dry-herb vaporizer cartridges. The company also manufactures various concentrates for vaporization, including pre-filled cartridges and disposable pens, alongside concentrates for dabbing, like distillate droppers. Further diversifying its portfolio, Curaleaf provides an assortment of infused goods, such as mints, topical balms and lotions, tinctures, lozenges, capsules, and edibles. Additionally, the firm supplies hemp-derived CBD products. As of June 16, 2022, Curaleaf maintained a substantial operational footprint across 22 U.S. states, comprising 134 dispensaries and 26 cultivation facilities. Founded in 2010, its corporate headquarters are located in Wakefield, Massachusetts.